These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 10972684

  • 1. Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo.
    Brown NJ, Nakamura S, Ma L, Nakamura I, Donnert E, Freeman M, Vaughan DE, Fogo AB.
    Kidney Int; 2000 Sep; 58(3):1219-27. PubMed ID: 10972684
    [Abstract] [Full Text] [Related]

  • 2. Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo.
    Nakamura S, Nakamura I, Ma L, Vaughan DE, Fogo AB.
    Kidney Int; 2000 Jul; 58(1):251-9. PubMed ID: 10886570
    [Abstract] [Full Text] [Related]

  • 3. Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1.
    Ma LJ, Nakamura S, Aldigier JC, Rossini M, Yang H, Liang X, Nakamura I, Marcantoni C, Fogo AB.
    J Am Soc Nephrol; 2005 Apr; 16(4):966-76. PubMed ID: 15728787
    [Abstract] [Full Text] [Related]

  • 4. Effect of combined AT1 receptor and aldosterone receptor antagonism on plasminogen activator inhibitor-1.
    Sawathiparnich P, Murphey LJ, Kumar S, Vaughan DE, Brown NJ.
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3867-73. PubMed ID: 12915681
    [Abstract] [Full Text] [Related]

  • 5. Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1.
    Ma LJ, Nakamura S, Whitsitt JS, Marcantoni C, Davidson JM, Fogo AB.
    Kidney Int; 2000 Dec; 58(6):2425-36. PubMed ID: 11115076
    [Abstract] [Full Text] [Related]

  • 6. Divergent effects of low versus high dose anti-TGF-beta antibody in puromycin aminonucleoside nephropathy in rats.
    Ma LJ, Jha S, Ling H, Pozzi A, Ledbetter S, Fogo AB.
    Kidney Int; 2004 Jan; 65(1):106-15. PubMed ID: 14675041
    [Abstract] [Full Text] [Related]

  • 7. Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition.
    Oikawa T, Freeman M, Lo W, Vaughan DE, Fogo A.
    Kidney Int; 1997 Jan; 51(1):164-72. PubMed ID: 8995730
    [Abstract] [Full Text] [Related]

  • 8. Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury.
    Oestreicher EM, Martinez-Vasquez D, Stone JR, Jonasson L, Roubsanthisuk W, Mukasa K, Adler GK.
    Circulation; 2003 Nov 18; 108(20):2517-23. PubMed ID: 14581407
    [Abstract] [Full Text] [Related]

  • 9. Spironolactone abolishes the relationship between aldosterone and plasminogen activator inhibitor-1 in humans.
    Sawathiparnich P, Kumar S, Vaughan DE, Brown NJ.
    J Clin Endocrinol Metab; 2002 Feb 18; 87(2):448-52. PubMed ID: 11836266
    [Abstract] [Full Text] [Related]

  • 10. Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.
    Ma LJ, Marcantoni C, Linton MF, Fazio S, Fogo AB.
    Kidney Int; 2001 May 18; 59(5):1899-910. PubMed ID: 11318962
    [Abstract] [Full Text] [Related]

  • 11. A clinical approach in regression of glomerulosclerosis.
    Stoian M, Radulian G, Chiţac D, Simion E, Stoica V.
    Rom J Intern Med; 2007 May 18; 45(2):215-8. PubMed ID: 18333378
    [Abstract] [Full Text] [Related]

  • 12. Beneficial effect of combined spironolactone and quinapril treatment on thrombosis and hemostasis in 2K1C hypertensive rats.
    Gromotowicz-Poplawska A, Stankiewicz A, Mikita J, Aleksiejczuk M, Marcinczyk N, Szemraj J, Chabielska E.
    J Physiol Pharmacol; 2018 Apr 18; 69(2):. PubMed ID: 29980144
    [Abstract] [Full Text] [Related]

  • 13. Effects of eplerenone on heart and kidney in two-kidney, one-clip rats.
    Hao L, Kanno Y, Fukushima R, Watanabe Y, Ishida Y, Suzuki H.
    Am J Nephrol; 2004 Apr 18; 24(1):54-60. PubMed ID: 14707436
    [Abstract] [Full Text] [Related]

  • 14. Aldosterone antagonism ameliorates proteinuria and nephrosclerosis independent of glomerular dynamics in L-NAME/SHR model.
    Zhou X, Ono H, Ono Y, Frohlich ED.
    Am J Nephrol; 2004 Apr 18; 24(2):242-9. PubMed ID: 15031627
    [Abstract] [Full Text] [Related]

  • 15. Mineralocorticoid receptor antagonism and aldosterone synthesis inhibition do not improve glomerulosclerosis and renal interstitial fibrosis in a model of chronic kidney allograft injury.
    Lahmer T, Hermans R, Schmaderer C, Chang J, Stock K, Lutz J, Heemann U, Baumann M.
    Kidney Blood Press Res; 2012 Apr 18; 35(6):561-7. PubMed ID: 22890233
    [Abstract] [Full Text] [Related]

  • 16. Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance.
    Ma J, Albornoz F, Yu C, Byrne DW, Vaughan DE, Brown NJ.
    Hypertension; 2005 Aug 18; 46(2):313-20. PubMed ID: 15998706
    [Abstract] [Full Text] [Related]

  • 17. [Effect of aldosterone on the expression of plasminogen activator inhibitor-1 in renal mesangial cells: experiment with rat renal mesangial cells].
    Yuan J, Jia RH, Bao Y.
    Zhonghua Yi Xue Za Zhi; 2007 Sep 11; 87(34):2439-42. PubMed ID: 18036328
    [Abstract] [Full Text] [Related]

  • 18. Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production.
    Brown NJ, Kim KS, Chen YQ, Blevins LS, Nadeau JH, Meranze SG, Vaughan DE.
    J Clin Endocrinol Metab; 2000 Jan 11; 85(1):336-44. PubMed ID: 10634408
    [Abstract] [Full Text] [Related]

  • 19. Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury.
    Ma J, Weisberg A, Griffin JP, Vaughan DE, Fogo AB, Brown NJ.
    Kidney Int; 2006 Mar 11; 69(6):1064-72. PubMed ID: 16528256
    [Abstract] [Full Text] [Related]

  • 20. A dynamic comparative study concerning the effects of angiotensin-converting enzyme inhibitors and aldosterone receptor blockers on the fibrinolytic system.
    Usalan C, Buyukhatipoglu H.
    Clin Appl Thromb Hemost; 2008 Apr 11; 14(2):203-9. PubMed ID: 18372278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.